Depressive symptoms and cognitive dysfunction in Post Covid-19 Condition

DOI Web Site Open Access
  • Takamasa Noda
    Department of Psychiatry, ​National Center of Neurology and Psychiatry ​Clinical Optic Imaging Section, Department of Clinical Neuroimaging, Integrative Brain Imaging Center, ​National Center of Neurology and Psychiatry Department of Neuropsychopharmacology, National Institute of Mental Health, National Center of Neurology and Psychiatry Department of Brain Bioregulatory Science, The Jikei University Graduate School of Medicine
  • Okabe Kaori
    Department of Psychiatry, ​National Center of Neurology and Psychiatry
  • Kanda Yasunari
    Division of Pharmacology, National Institute of Health Sciences
  • Nishida Motohiro
    Department of Physiology, Graduate School of Pharmaceutical Sciences, Kyushu University

Bibliographic Information

Other Title
  • COVID-19後遺症として生じる抑うつ症状、認知機能障害

Description

<p>There are over 565 million people infected with COVID-19 and 6 million deaths in the world. All patients infected COVID-19 may experience post COVID-19 conditions. Conditions after COVID-19 infection have wide range symptoms lasting for 12 weeks or more. Most prevalent neurological and psychiatric symptoms were fatigue, cognitive dysfunction, depressive symptoms, and sleep disturbance. And patients with post COVID-19 conditions have an impairment of health-related quality of life. However, there is no specific treatment for this condition. At the conference, we will present the treatment of cognitive dysfunction and depressive symptoms in the patients with post COVID-19 conditions.</p>

Journal

Keywords

Details 詳細情報について

Report a problem

Back to top